A pH-sensitive liposome formulation of a peptidomimetic-Dox conjugate for targeting HER2 + cancer

International Journal of Pharmaceutics(2022)

引用 12|浏览11
暂无评分
摘要
•A pH-sensitive liposome containing peptidomimetic-doxorubicin conjugate was developed.•The formulation was able to release more the drug conjugate at pH 6.5 comapred to 7.4.•The cellular uptake of the conjugate was high in HER2 positive cancer cells.•The formulation exhibited anticancer activity in 3D tumor spheroid model.•The formulation was able to suppress the NSCLC tumor in mice model.
更多
查看译文
关键词
pH-sensitive liposome,Doxorubicin,Peptide conjugate,Lung cancer,HER2
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要